跳至主要内容
临床试验/NCT01934036
NCT01934036已完成2 期

Efficacy and Safety of Obex®, a Nutritional Supplement, in Overweight or Obese Women

Catalysis SL1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Catalysis SL
入组人数
92
试验地点
1
主要终点
To evaluate the effect of OBEX on skinfolds

研究概览

简要总结

The aim of the study is to evaluate the effects of a dietary supplement (Obex®) on anthropometric and physiological variables in Spanish women between 35 and 60 years who are overweight or obese.

详细描述

The nutritional supplement consists of natural plant extracts such as Caralluma fimbriata, Phaseolus vulgaris, Acai Berry and other antiobesity agents: ornithine, carnitine fumarate, essential fatty acids and certain amino acids, vitamins and minerals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged between 35 and 60 years.
  • Body Mass Index (BMI) greater than 27 kg/m² and lower than 35 kg/m²
  • Ability to provide informed consent

排除标准

  • Presence of any endocrine, hepatic, renal or cardiovascular disease.
  • History of bariatric surgery
  • Pregnancy or lactation
  • Concomitant disease with reduced life expectancy
  • Severe psychiatric conditions
  • Drug dependence

研究组 & 干预措施

Obex, a nutritional supplement

Experimental

Obex will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.

干预措施: Obex (Dietary Supplement)

Placebo

Placebo Comparator

Placebo will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.

干预措施: Placebo (Drug)

结局指标

主要结局

To evaluate the effect of OBEX on skinfolds

时间窗: Two months of treatment and three months after concluded the treatment

The primary outcome is to evaluate the effect of the treatment with OBEX on skinfold thickness of the biceps, triceps, subscapular and suprailiac as compared to placebo group at 2 months of treatment.

次要结局

  • To evaluate the effect of OBEX on the waist and hip circumferences(Two months of treatment and three months after concluded the treatment)
  • To evaluate the effect of Obex on the arm circumference.(Two months of treatment and three months after concluded the treatment)
  • To evaluate the effect of Obex on the percentage of body fat(Two months of treatment and three months after concluded the treatment)
  • To evaluate the effect of Obex on the muscular mass(Two months of treatments and three months after concluded the treatment)
  • To evaluate the effect of Obex on arterial blood pressures.(Two months of treatment and three months after concluded the treatment)
  • To evaluate the effect of Obex on fasting glucose and cholesterol levels(Two months of treatment and three months after concluded the treatment)

研究者

发起方
Catalysis SL
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验